Latest Standards Updates
Extended Implementation and Comment Period Extension for USP–NF and FCC Publications (posted 27–Mar–2020)
Two New Interim Revision Announcements (posted 27–Mar–2020)
One New Pending Notice of Intent to Revise (posted 27–Mar–2020)
Two New Notices of Intent to Revise (posted 27–Mar–2020)
Four New Publication Announcements (posted 27–Mar–2020)
One New General Announcement (posted 27–Mar–2020)
Cumulative List Updated (posted 27–Mar–2020)
One New Revision Bulletin (posted 23–Mar–2020)
200 years of building trust
The United States Pharmacopeia (USP) was created nearly 200 years ago, dedicated to instilling trust where it matters most: in the medicines, supplements and foods people rely on for their health. The quality standards we develop help manufacturers deliver on their promises of safe products, while building confidence among healthcare practitioners, patients and consumers.
FDA Commissioner welcomes USP Convention Members
Commissioner Hahn reflects on the FDA’s shared history with USP to improve public health and protect patient safety, including current efforts to combat COVID-19.
Will we have access to enough safe, quality medicines?
As the impact of the COVID-19 pandemic continues to unfold, each day brings to light new realizations of just how interconnected, and sometimes vulnerable, the global supply chain for medicines is.